Navigation Links
Starion Achieves Worldwide Distribution of Proprietary Tissue Welding Technology
Date:1/31/2008

Researchers in South Africa latest to report patient benefits

SUNNYVALE, Calif., Jan. 31 /PRNewswire/ -- Starion Instruments, a leading surgical device company, today announced that it has extended worldwide distribution of its proprietary tissue welding technology. Physicians in North America, Europe, the Middle East, Africa, and Asia now have access to safe, effective and precise instruments for a wide variety of surgical procedures.

Sealing and dividing soft tissue is an essential part of surgery. Unlike conventional products which use indirect forms of energy: ultrasonic or bipolar radio frequency, Starion instruments perform sealing and dividing with direct heat and pressure. Studies have shown that this method minimizes thermal spread, reduces the risk of collateral damage and decreases patient recovery times.

"Surgeons worldwide are demanding technologies that enhance performance, minimize risk and improve patient outcomes," said Kirt Kirtland, president and chief executive officer of Starion Instruments. "We are excited that our products and value proposition have expanded our reach across the globe."

In South Africa, for example, surgeons are using the company's products in a wide variety of cardiology, general surgery, gynecology, and otolaryngology procedures. The next anticipated areas of expansion are China and Japan, where regulatory approvals are pending.

As Starion's influence grows beyond the U.S., leading researchers from Greece to Taiwan are reporting the benefits of tissue welding technology versus other modalities. Most recently, Lance Maron, MBBCh, FCS (SA), from Netcare Parklane Hospital in Johannesburg, South Africa, presented his findings at the 43rd South African National ENT & SAHNOS Congress.

During the Congress, Maron reported that Starion's forceps are easy to use, cause minimal intra-operative blood loss, facilitate complete removal of tonsils resulting in rapid healing and recovery with less post-operative pain and a fast return to normal diet and school/work.

About Starion Instruments

Starion Instruments is dedicated to developing advanced surgical devices that enhance performance, minimize risk and improve patient outcomes. Starion's instruments employ a proprietary Tissue Welding technology that seals and divides soft tissue while minimizing the risk of collateral damage. Known for their effectiveness, reliability and versatility, Starion's products are used by surgeons worldwide for open and endoscopic cardiac, gynecology, general surgery, otolaryngology and urology procedures. For more information, please visit the company's website at http://www.starioninstruments.com.


'/>"/>
SOURCE Starion Instruments
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Society of Laproendoscopic Surgeons Names Starion Instruments 2007 Innovator of the Year
2. Surface Logix Achieves Objectives With SLx-4090 in Phase 2a Clinical Trial
3. Pharsight Achieves $7.4 Million in Quarterly Revenue
4. Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
5. BIAS Achieves Certified Advantage Partner Level in Oracle PartnerNetwork
6. NOLabs AB Achieves Break-Through in Fight Against MRSA-Bacteria
7. Sigma-Aldrich Achieves Double Accreditation as a Certified Reference Material Producer Following ISO/IEC 17025 and ISO Guide 34
8. BioMS Medical achieves enrollment milestone in U.S. phase III multiple sclerosis trial
9. Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.
10. Diplomat Specialty Pharmacy Health Services Division Achieves High Marks in Pilot Program for Chronic Kidney Disease Management
11. Signalife Achieves $1.98 Million Sales Orders Thus Far
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ... flexible packaging for their exceptionally efficient human mesenchymal stem/stromal cell (hMSC) expansion ... of bioprocess media products engineered to radically streamline culture processes, minimize processing ...
(Date:12/8/2016)... , Dec. 8, 2016  HedgePath Pharmaceuticals, ... that discovers, develops and plans to commercialize innovative ... shares of common stock were approved for trading ... begin trading on the OTCQX, effective today, under ... for the OTCQX market, companies must meet high ...
(Date:12/7/2016)... ... December 07, 2016 , ... ACEA Biosciences, Inc. ... and expansion clinical trial for its lead drug candidate, AC0010, at the World ... trial was to determine the safety, antitumor activity, and recommended phase II dosage ...
(Date:12/7/2016)... /PRNewswire/ - Zenith Capital Corp. ("Zenith" or the "Company") announces webcast ... the Company,s Annual and Special Meeting. The ... on Thursday, December 15, 2016 at Mount Royal ... 4825 Mount Royal Gate SW, Calgary, Alberta ... and management information circular, containing the matters to be considered ...
Breaking Biology Technology:
(Date:12/2/2016)... Dec. 1, 2016   SoftServe , a ... BioLock , an electrocardiogram (ECG) biosensor analysis system ... key IoT asset. The smart system ensures device-to-device ... steering wheel and mobile devices to easily ,recognize, ... As vehicle technology advances, so too must ...
(Date:11/29/2016)... VILNIUS, Lithuania , Nov. 29, 2016 ... high-precision biometric identification and object recognition technologies, ... kit (SDK) for fingerprint recognition solutions that ... extract a fingerprint template using less than ... used in compact devices that have limited ...
(Date:11/22/2016)... According to the new market research report "Biometric ... Signature, Voice), Multi-Factor), Component (Hardware and Software), Function (Contact and Non-contact), Application, ... is expected to grow from USD 10.74 Billion in 2015 to reach ... and 2022. Continue Reading ... ...
Breaking Biology News(10 mins):